A multi-centre, randomized, placebo-controlled, double-blinded trial to assess the efficacy and safety of FlowOxTM on walking distance compared to Standard of Care (SoC) in patients with peripheral arterial disease (PAD) and intermittent claudication
Beteiligte Wissenschaftler*innen:
Akad. Rat Dr. Dipl.-Stat. J. Gerß
MSc. Math K. Kreitz
Projektleitung:
Prof. Dr. H. von der Leyen